With all due respect, there has been huge interest from the medical arena in initiating INDs with Intellicell. Prominent folks. With that there will naturally be money waiting in the wings for stem cell/biotech activities. Therefore, more likely is this equity will rise from the ashes WHEN or IF they get a protocol that works good enough for FDA/Andrews...
IMO financing is there. Technology and patents (EPO) apparently not..... Yet.
News 
Market Data 
Discover 
